James Sahn

James Sahn serves as the Vice President of Drug Development at 4E Therapeutics Inc. since May 2019 and co-founded NuvoNuro, Inc. in August 2016, where involvement continues. Prior experience includes roles as a Research Scientist and Research Associate at The University of Texas at Austin from October 2014 to September 2019, and as a Research Associate at the Texas Institute for Drug and Diagnostic Development from August 2011 to September 2014. Additionally, James Sahn was a Research Fellow at the University of Texas at Austin from January 2009 to September 2011 and completed a PhD under Dr. Daniel Comins at North Carolina State University from August 2003 to December 2008, focusing on alkaloid natural product synthesis and photochemical [2+2] cycloadditions. James Sahn holds a Doctorate in organic synthesis from North Carolina State University.